These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 187767)

  • 21. Studies on Epstein-Barr virus-related antigens. II. Biochemical properties of soluble antigen in Raji Burkitt lymphoma cells.
    Matsuo T; Nishi S; Hirai H; Osato T
    Int J Cancer; 1977 Mar; 19(3):364-70. PubMed ID: 14897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complementation between infecting Epstein-Barr virus and intrinsic viral genomes in human lymphoid cell lines.
    Lidin BI; Lamon EW; Cloud G; Soong SJ
    Intervirology; 1982; 18(1-2):66-75. PubMed ID: 6288617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine.
    Yamamoto N; Mueller-Lantzsch N; zur Hausen H
    Int J Cancer; 1980 Apr; 25(4):439-43. PubMed ID: 6246007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatic cell hybrids between human lymphoma cell lines. V. IdUrd inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines.
    Moar MH; Ber R; Klein G; Westman A; Eriksson I
    Int J Cancer; 1978 Dec; 22(6):669-74. PubMed ID: 82545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody.
    Lin JC; Choi EI; Pagano JS
    J Virol; 1985 Mar; 53(3):793-9. PubMed ID: 2983091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification of soluble complement-fixing antigens from two Burkitt's lymphoma cell lines. Conditions affecting the stability and recovery of antigens and antibodies.
    Weliky N; Leaman DH; Kallman BJ
    Immunology; 1975 Oct; 29(4):779-90. PubMed ID: 241721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a purified complement-fixing antigen as the Epstein-Barr-virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes.
    Ohno S; Luka J; Lindahl T; Klein G
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1605-9. PubMed ID: 67603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection localization of Epstein-Barr virus-associated early antigens in single cells by autoradiography using 125I-labeled antibodies. (With 1 color plate).
    Moar MH; Siegert W; Klein G
    Intervirology; 1977; 8(4):226-39. PubMed ID: 194866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV.
    Fresen KO; Cho MS; zur Hausen H
    Int J Cancer; 1978 Oct; 22(4):378-83. PubMed ID: 212377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attempts to induce interferon production by IdUrd induction and EBV superinfection in human lymphoma lines and their hybrids.
    Klein G; Vilcek J
    J Gen Virol; 1980 Jan; 46(1):111-7. PubMed ID: 6243338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Epstein-Barr virus early antigen-D and its antibodies by passive hemagglutination.
    Ogburn CA; Zajac BA
    Int J Cancer; 1977 Feb; 19(2):150-60. PubMed ID: 190173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
    Sculley TB; Spelsberg TC; Pearson GR
    Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential inducibility of Epstein-Barr virus in cloned, non-producer Raji cells.
    Bister K; Yamamoto N; zur Hausen H
    Int J Cancer; 1979 Jun; 23(6):818-25. PubMed ID: 89100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanisms.
    Kurakata S; Ramos OF; Klein G; Klein E
    Cell Immunol; 1989 Oct; 123(1):134-47. PubMed ID: 2550147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen.
    Kishishita M; Luka J; Vroman B; Poduslo JF; Pearson GR
    Virology; 1984 Mar; 133(2):363-75. PubMed ID: 6324457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen-inducing ability of herpesvirus papio in human and baboon lymphoma lines, compared to Epstein-Barr virus.
    Klein G; Falk L; Falk K
    Intervirology; 1978; 10(3):153-64. PubMed ID: 210135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential induction of Epstein-Barr virus-related antigens in human lymphoblastoid cells by virus-mediated cell-to-cell contact.
    Matsuo T; Yamamoto K; Osato T
    Int J Cancer; 1976 Apr; 17(4):423-8. PubMed ID: 179955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polypeptides of the Epstein-Barr virus membrane antigen complex.
    Thorley-Lawson DA; Edson CM
    J Virol; 1979 Nov; 32(2):458-67. PubMed ID: 228070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of D and R components of Epstein-Barr virus early antigen after superinfection and after induction with 5-iododeoxyuridine.
    Simonová I; Závadová H; Vonka V
    Acta Virol; 1977 May; 21(3):184-8. PubMed ID: 18915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
    Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
    J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.